“Brand Name or Equal” Nanalysis AUTOsample-100 autosampler
The FDA is conducting market research to identify small business sources capable of providing a "Brand Name or Equal" Nanalysis AUTOsample-100 autosampler for use with an existing NMR system in Saint Louis, MO. The autosampler must be fully compatible with the government-owned Nanalysis 100-PRO benchtop NMR system and meet specific minimum technical requirements, including automated sample queuing and processing without operator intervention. Delivery of the newly manufactured, turn-key system must occur within 60 calendar days from the date of award, with installation and on-site training provided at the FDA facility in St. Louis, MO. Responses to this sources sought notice are due by May 26, 2026, at 1:00 PM Central Time, and must include capability statements, past performance information, and descriptive literature. No budget amount is specified, and this notice is for market research only, not a solicitation for proposals.